TPG Capital, CPP Investment Board and Leonard Green & Partners have completed their $4.2 billion private buyout of IMS Health. The investors paid $22 per share for the company, a 50% premium to IMS's stock price at the time of the announcement. The deal also included approximately $1.2 billion of assumed liabilities, valuing the deal at a total of $5.4 billion. The deal was financed with a $2 billion senior term loan, $1 billion of senior notes and a $275 million revolver. IMS provides market intelligence to pharmaceutical and healthcare industries worldwide.